|
|
# 2024 Sonorus |
|
An AI-powered medical tool enhancing the diagnosis of rheumatic heart disease (RHD), a preventable yet serious condition, Sonorus uses advanced algorithms to analyse heart sounds and detect murmurs with 80% specificity. Designed for ease of use without specialist training, it can be deployed in settings with limited healthcare access. The technology leverages machine learning to continuously improve its diagnostic accuracy. Current efforts are focused on refining the algorithms and ensuring reliable performance in diverse clinical environments
Dr Julie Dao recently completed her PhD in the Cardiovascular Disease Program at Monash University (Monash Health). Her research was focused on uncovering novel mechanisms to target when preventing cardiovascular disease. Julie worked alongside supervisors Professor Stephen Nicholls and Dr Kristen Bubb of the Vascular Pathophysiology and Therapeutics Group. Julie is passionate about positive impact through medical technology which led her to co-found Sonorus. Sonorus is a medical device and AI company aimed at democratizing cardiovascular specialty expertise through the use of bioacoustic signatures. Her work has gained her a Forbes-30-Under-30 Nomination for Healthcare and Science in Australia and Asia. more
Nanyang Technological University
Targeted antimicrobial treatment for resistant infections
